Ætio-pathogenic hypotheses of attention deficit disorder of childhood;Hypothèses étiopothogéniques de l'hyperoctivité avec troubles de l'attention de l'enfant

Revue du Praticien

Volumn 52, Issue 18, 2002, Pages 1994-1997

  Reneric, Jean Philippe ^a   Bouvard, Manuel P ^a  

^a CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CATECHOLAMINERGIC SYSTEM; CHILD; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; HUMAN; PATHOGENESIS; REVIEW; SYMPTOMATOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CEREBRAL CORTEX; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RECEPTORS, DOPAMINE;

EID: 0037112802     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996; 37: 51-87.
2. Barkley RA. Behavioral inhibition, sustained attention,and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65-94.
3. Quay HC. Inhibition and attention deficit hyperactivity disorder. J Abnorm Child Psychol 1997; 25: 7-13.
4. Schachar R, Logan GD, Impulsivity and inhibitory control in normal development and childhood psychopathology. Develop Psychol 1990; 26: 710-20.
5. Sonuga-Barke EJ,Williams E, Hall M, Saxton T. Hyperactivity and delay aversion. III: The effect on cognitive style of imposing delay after errors. J Child Psychol Psychiatry 1996; 37: 189-94.
6. Sergeant JA.The Cognitive-Energetic Model of ADHD. Society for Research in Child and Adolescent Psychopathology. Los Angeles, CA: 1996.
7. Solanto MV. Behavioral effects of low-dose methylphenidate in childhood attention deficit disorder: Implications for a mechanism of stimulant drug action. J Am Acad Child Psychiatry 1986; 25: 96-101.
8. Castellanos FX, Elia J, Kruesi MJ et al. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorden Neuropsychopharmacology 1996; 14: 125-37.
9. Michelson D, Faries D, Wernicke J et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo controlled, dose-response study. Pediatrics 2001; 108: E83.
10. Castellanos FX, Giedd JN, Marsh WL et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 607-16.
11. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J.Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48: 589-601.
12. Zametkin AJ, Nordahl TE, Gross M et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset [see comments]. N Engl J Med 1990; 323: 1361-6.
13. Lou HC. Methytphenidate reversible hypoperfusion of striatal regions in ADHD. In: Conners K, Kinsbourne M (eds).Attention Deficit Hyperactivity Disorder. Munich: MMV Medizin Verlag, 1990: 137-48.
14. Lou HC, Henriksen L, Bruhn R Borner H, Nielsen JB. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1989; 46: 48-52.
15. Tannock R. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 1998; 39: 65-99.
16. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions:a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997; 36: 745-53.
17. Morrison JR, Stewart MA. The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 1973; 28: 888-91
18. van den Oord EJ, Boomsma DI,Verhulst FC.A study of problem behaviors in 10-to 15-year-old biologically related and unrelated international adoptees. Behav Genet 1994; 24: 193-205.
19. Cook EH, Jr, Stein MA, Krasowski MD et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-8.
20. LaHoste GJ, Swanson JM,Wigal SB et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder [see comments]. Mol Psychiatry 1996; 1: 121-4.
21. Swanson JM, Sunohara GA, Kennedy JL et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD):a family-based approach. Mol Psychiatry 1998; 3: 38-41.
22. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65: 1157-65.
23. Sprich-Buckminster S, Biederman J, Milberger S, Faraone SV, Lehman BK.Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality [see comments]. J. Am Acad Child Adolesc Psychiatry 1993; 32: 1032-7.
24. Biederman J, Milberger S, Faraone SV et al. Family-environment risk factors for attention-deficit, hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry 1995; 52: 464-70.
25. Offord DR, Boyle MH, RacineYA et al. Outcome, prognosis, and risk in a longitudinal follow-up study [see comments]. J. Am Acad Child Adolesc Psychiatry 1992; 31: 916-23.